A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients
Jayme E. Locke(New York University), Dorry L. Segev(New York University), Allan B. Massie(Johns Hopkins University), Shikha Mehta(University of Alabama at Birmingham), Paul A. MacLennan(University of Alabama at Birmingham), Anoma Nellore(NYU Langone Health), Rhiannon D. Reed(University of Alabama at Birmingham), Christine M. Durand(University of Maryland, Baltimore)
Cited by 137
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
|Immunity|2012|707
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
|Journal of Clinical Oncology|1997|706